The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation
about
Immune regulation of human herpesviruses and its implications for human transplantationThe interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseDefining immune engagement thresholds for in vivo control of virus-driven lymphoproliferationViral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolutionViruses and human cancers: a long road of discovery of molecular paradigms.Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherinMolecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.Immune escape of γ-herpesviruses from adaptive immunityAn Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.PML nuclear bodies and SATB1 are associated with HLA class I expression in EBV+ Hodgkin lymphomaEpstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytesIdentification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected CellsInferring Infection Patterns Based on a Connectivity Map of Host Transcriptional Responses.Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activationEBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.Immune regulation and evasion of Mammalian host cell immunity during viral infection.Mutations in the C-terminal region affect subcellular localization of crucian carp herpesvirus (CaHV) GPCR.Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunityProspects of a novel vaccination strategy for human gamma-herpesviruses.Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.Epstein-Barr virus genetics: talking about the BAC generation.Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses.Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?Cytomegalovirus immune evasion by perturbation of endosomal trafficking.Hijacking GPCRs by viral pathogens and tumor.The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-IIEBV glycoproteins: where are we now?Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.Epstein-Barr virus: more than 50 years old and still providing surprises.
P2860
Q26992146-68B13A0D-D9D8-4026-945D-D2ADB2AEB0BCQ26998401-5755A753-EC0B-42AB-BD8D-14F6F3FC432FQ27324746-2E692DF8-0AB5-4A83-B242-2597625235B7Q28083232-2A86AC16-D6D7-4D55-AF33-A9CB047EE7E3Q30384388-B6AA89C7-CC10-4D1D-87E2-807FA78ECD54Q33474804-13F930EA-C212-4001-B009-1822ED883700Q33564429-0B2A743C-F0CA-4E0C-A9F8-B9E3B25A2B86Q33819076-5A246480-DDC0-4055-87C4-8E31B78D0F23Q34116845-898F3580-3CEB-4A0F-B1D7-03F6066085D3Q34121692-17E4B465-5311-4D60-ABDC-C597083BD410Q34310840-F8738E71-E95E-4CEA-B2BF-8B7E8DD4EA1CQ34345549-C006E95B-56A6-47ED-83C9-7A9F2B4AC627Q34539785-9B7104DC-B8F5-408B-A48C-B67281CCDBB3Q34979670-E9F5FEFD-136F-4B2C-A0EF-BF91AD6338CEQ35077651-DC021F71-786D-4F7E-AB80-1DD81F53CF77Q35115637-D9F468B7-26E7-4C5F-895A-DB1D1B4E7AE9Q35158385-49F9F75D-AE53-4483-AD78-0AC42FEFC2A4Q35531669-0EC3EAED-BFB9-48D8-B518-750FA7711426Q35661383-1D5B5EC7-530F-4DAC-B456-0192123BBBEEQ35989470-562AAAB8-8377-479A-A9AD-2000EA34ADA8Q36217014-350480F6-DDD2-413A-8759-7D9FA71028A3Q36395876-F7B9A9B2-3B87-4D1F-84E6-F637DDC80963Q36590231-7EC13B83-0148-4B5C-8C41-4423B451FDEAQ36832077-7C212056-8433-48F6-B789-D7AF9F0B23D5Q37043094-D3AA7A05-CEA8-4FCE-8040-719802FBCC0CQ37123246-41A2A524-E5E9-4ADA-8F0F-D1DF9D31E650Q37272108-4981C551-82D9-4D39-A124-48DE64E7C7DDQ37369220-A2932560-AF38-4BFF-ACF9-8A4A035C0A58Q37652046-5F13629A-B0CE-4A75-95E1-5C517691FE80Q37780705-0DFCCDB9-B1B4-4DB7-A0BF-F07D7C460BC3Q37837495-BC5A0E11-C9DF-41F8-B374-5972CD10A931Q37856451-0A438226-9B6F-4F6E-BDE0-D3D16BB45B6AQ38111863-125CEC79-7D84-4A03-BF3D-34B66BAE2346Q38180332-92D9F3E1-2A9E-4F3D-A9AE-1A51A1C347C9Q38255071-1356F72D-ECE5-4868-BE20-2530C4FA2C1CQ38802773-BD63C396-2260-415F-8A73-67D2455B4DCBQ38827812-8D2FF666-FAE6-4083-8C29-40E08DAF07A1Q38912277-EE30195C-D39D-4988-8416-E8447B950712Q38953504-B0156219-DF51-4C78-BBA6-5907E4F96F2DQ38968588-45D5134F-4948-4318-9124-226D099984BD
P2860
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The Epstein-Barr virus G-prote ...... ss I molecules for degradation
@ast
The Epstein-Barr virus G-prote ...... ss I molecules for degradation
@en
type
label
The Epstein-Barr virus G-prote ...... ss I molecules for degradation
@ast
The Epstein-Barr virus G-prote ...... ss I molecules for degradation
@en
prefLabel
The Epstein-Barr virus G-prote ...... ss I molecules for degradation
@ast
The Epstein-Barr virus G-prote ...... ss I molecules for degradation
@en
P2093
P2860
P50
P1433
P1476
The Epstein-Barr virus G-prote ...... ss I molecules for degradation
@en
P2093
Andrew Currin
Claire Shannon-Lowe
Emmanuel J H J Wiertz
Maaike E Ressing
Wendy A Thomas
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000255
P577
2009-01-02T00:00:00Z